Predictors of Early Discontinuation of Effective Contraception by Teens at High Risk of Pregnancy

Maslyanskaya, Sofya; Coupey, Susan M.; Chhabra, Rosy; Khan, Unab I.

doi:10.1016/j.jpag.2015.10.014

Cited by 22 publications

(18 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study revealed that within the 12-month observation period, one-fifth (20.11%) of the analytical sample has discontinued contraceptive methods while at risk of becoming pregnant. Most discontinuations however occurred because of a desire to become pregnant (47.97%), method failure (15.24%), and the need for a more effective method (8.96%) among others and is similar to the previous studies [7,17,18]. The adjusted odds ratio of discontinued contraception while still at risk of becoming pregnant from a binary logistic regression model revealed that women who have experienced any form of IPV are 1.28 times more likely to have discontinued contraception while still at risk of becoming pregnant than those who have not experienced IPV.…”

Section: Discussionsupporting

confidence: 86%

“…Reasons for contraceptive discontinuation as well as the different brands of contraceptives discontinued among married women are well documented and have shown that contraceptive discontinuation often occurred within a year of adoption of a method [14,15] while the median duration of the use of contraception before discontinuation gets closer to 2 years [7]. Side effects, method failure, menstrual disruption, husband/spousal disapproval, menopause, fear of infertility, and desire for more children are cited as reasons for contraceptive discontinuation [7,[16][17][18]. Other contributing predictors include age, marital status, parity, education, place of residence, occupation, household income, number of under-five children, and men's occupation [15,19,20].…”

Section: Introductionmentioning

confidence: 99%

“…Prior studies on the relationship between contraceptive discontinuation and IPV showed mixed results [7,31,32]. Discontinuation rates, however, differ reliably by methods [7,17,18]. For instance, a limited sign of association was found between IPV and the odds of contraceptive discontinuation [9].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Intimate partner violence as a factor in contraceptive discontinuation among sexually active married women in Nigeria

Kupoluyi

2020

BMC Women's Health

View full text Add to dashboard Cite

Background: In spite of the well-established associations between socioeconomic and demographic factors and the high rate of contraceptive discontinuation among sexually active married contraceptive users, little is known in Nigeria about the relationship between contraceptive discontinuation and sexually active married women who have experienced Intimate Partner Violence (IPV). Methods: The 2013 Nigeria Demographic and Health Survey data on women's reproductive calendars and domestic violence were used to investigate the relationship between IPV and contraceptive discontinuation in a year period. A weighted sample size of 1341 women in a union in the domestic violence module, who have experienced IPV, and are using any contraceptive and are not sterilized in the 12 months periods was analyzed using frequency tables and chart, Pearson's chi-square test, and binary logistic regression model. Results: The results showed that women who have experienced any type of IPV are 1.28 times more likely to have discontinued contraceptive use although they are still at risk of becoming pregnant (aOR = 1.28, CI: 1.15-1.91; p < 0.05) than those who have not experienced IPV. The tertiary level of education (aOR = 3.94, CI = 1.67-9.29; p < 0.05), unemployed status (aOR = 1.97, CI = 1.07-3.62; p < 0.05), and higher marital duration of 20 years and above (aOR = 4.89, CI = 2.26-10.57; p < 0.05) significantly influenced women who have experienced any types of IPV to discontinue contraceptives even though they are still at risk of becoming pregnant than those who have not experienced IPV. Conclusion: The study revealed that women who have experienced any form of IPV were significantly influenced by their education, occupation, the number of living children, and marital duration to discontinue contraception while still at risk of becoming pregnant. Thus, the study concludes that intervention programmes aimed at increasing contraceptive prevalence rate should be mindful of IPV which may affect women's use of contraceptives.

show abstract

Section: Discussionsupporting

confidence: 86%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Intimate partner violence as a factor in contraceptive discontinuation among sexually active married women in Nigeria

Kupoluyi

2020

BMC Women's Health

View full text Add to dashboard Cite

show abstract

“…Six-month continuation rates were lowest with the patch and ring at 17%, compared to 88% with the IUD, 20% with the injectable, and 43% with COCs. Of the 23 who chose the patch or ring, 11 never initiated, 2 continued, and 10 discontinued 25. It is important to note that this was a small study and reasons for not initiating or discontinuing methods were not reported.…”

Section: Patient Satisfactionmentioning

confidence: 99%

Transdermal delivery of combined hormonal contraception: a review of the current literature

Galzote

Rafie

Teal

et al. 2017

IJWH

View full text Add to dashboard Cite

The transdermal patch provides an effective and convenient option for hormonal contraception. The patch currently on the US market contains 150 µg norelgestromin and 35 µg ethinylestradiol (EE). The 20 cm2 patch is applied once weekly for 3 weeks, followed by a patch-free week, for a 21–7 cycle. Typical failure rates are similar to that of combined oral contraceptives (COCs). Transdermal delivery results in less peaks and troughs of estrogen, but a higher total estrogen exposure compared with COCs. Though studies show mixed results, the risk of developing venous thromboembolism (VTE) is about twice as high with the patch as with COCs; however, the absolute risk of VTE remains low. The side effect profile is similar to that of COCs, with slightly higher rates of breast tenderness plus a unique adverse effect of application site reactions. Two new patches have been developed, one containing gestodene and EE in Europe and another containing levonorgestrel and EE. Overall, the patch provides an alternative to COCs for women who want autonomy and the benefit of not needing to take a pill daily, with similar efficacy and tolerability.

show abstract

“…Prior analyses of racial differences in contraceptive discontinuation have been mixed; most, but not all, have found higher rates of discontinuation among black women. [16][17][18][19][20][21][22][23] We hypothesized that previously observed differences in contraceptive discontinuation were attributable to barriers to care and service that differentially affect black women. In this analysis, we examined whether there were significant differences in discontinuation between black and white women stratified by use of long-and short-acting contraceptive methods which have different barriers to continuation.…”

Section: Introductionmentioning

confidence: 99%

Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project

Allsworth

Secura

Ajibade

et al. 2018

Journal of Women's Health

View full text Add to dashboard Cite

show abstract

Predictors of Early Discontinuation of Effective Contraception by Teens at High Risk of Pregnancy

Cited by 22 publications

References 24 publications

Intimate partner violence as a factor in contraceptive discontinuation among sexually active married women in Nigeria

Intimate partner violence as a factor in contraceptive discontinuation among sexually active married women in Nigeria

Transdermal delivery of combined hormonal contraception: a review of the current literature

Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project

Contact Info

Product

Resources

About